Skip to main content

Month: August 2022

Qualis Innovations Inc. will Present at the 16th PAINWEEK Conference September 6-9 at The Cosmopolitan Of Las Vegas

Chadds Ford, Pennsylvania, Aug. 22, 2022 (GLOBE NEWSWIRE) — Qualis Innovations Inc. currently trades under symbol “QLIS”, will be presenting at PAINWEEK 2022. The conference will be held from September 6-9 at The Cosmopolitan of Las Vegas. Our Chief Executive Officer, Dr. Joseph V. Pergolizzi, Jr will be presenting at the conference. The abstract will focus on non-invasive devices that may augment the treatment of musculoskeletal pain conditions. Dr. Joseph V. Pergolizzi, Jr. has been our acting Chief Executive Officer since October 2021 Dr. Pergolizzi is an internationally recognized thought leader in anesthesiology, internal medicine, perioperative care, pain medicine, critical and palliative care, pharmacology, drug development, and regulatory affairs. As a drug and device regulatory subject matter expert. He is the co-founder...

Continue reading

First Guaranty Bancshares, Inc. Declares 117th Consecutive Quarterly Cash Dividend to Shareholders

HAMMOND, La., Aug. 22, 2022 (GLOBE NEWSWIRE) — On August 18, 2022 the Board of Directors of First Guaranty Bancshares, Inc. (“First Guaranty”) declared a quarterly cash dividend on First Guaranty’s outstanding shares of common stock of $0.16 per share. The dividend will be payable to shareholders of record as of September 23, 2022 and is expected to be paid on September 30, 2022. This is the 117th consecutive quarterly dividend paid to common shareholders. Sincerely, Alton B. LewisPresident and CEOFirst Guaranty Bancshares, Inc. About First Guaranty First Guaranty Bancshares, Inc. is the holding company for First Guaranty Bank, a Louisiana state-chartered bank. Founded in 1934, First Guaranty Bank offers a wide range of financial services and focuses on building client relationships and providing exceptional customer service. First...

Continue reading

Graphex Technologies Highlights U.S. Expansion Progress and Outlines Business Strategy

The international technology company advances plans to increase graphite production globally and to localize mid-stream critical mineral supply chains, including its first production facility in the U.S. ROYAL OAK, Mich., Aug. 22, 2022 (GLOBE NEWSWIRE) — Graphex Technologies LLC, a wholly owned U.S. subsidiary of Graphex Group Limited (NYSE American: GRFX | HKSE: 6128, collectively “Graphex”), a global leader in mid-stream processing of specialized natural graphite used for electric vehicle (EV) lithium-ion (Li-ion) batteries, today provided an update that reflects on milestones achieved in 2022 and its objectives for the remainder of the year.  The expansion of Graphex Technologies’ presence in the U.S. – and more specifically in Warren, MI, the heart of the automotive sector – comes at a critical moment in global...

Continue reading

E-Home Household Service Holdings Limited Announces Unaudited Preliminary Operational Matric for Fiscal Year Ended June 30, 2022

Fuzhou, Aug. 22, 2022 (GLOBE NEWSWIRE) — E-Home Household Service Holdings Limited (NASDAQ: EJH) (the “Company” or “E-Home”), a provider of integrated household services in China, today announced unaudited preliminary operation matric for fiscal year ended June 30, 2022 (key matric are not disclosed as it’s unaudited) as the Company’s business performance is picking up quickly amid China’s endeavor to resume normal operation of businesses operating in different sectors. The company is expected to achieve a significant increase in revenue and positive net profit growth for the fiscal year ending June 30, 2022. E-Home is anticipated to report more than 3 million registered members as of June 30, 2022, with over 2 million members using the Company’s services during the same reporting period. In total the Company is expected to receive...

Continue reading

With 11.2% CAGR, Medical Carts Market Size worth USD 1512.8 Million in 2026

According to Fortune Business Insights, The global medical carts market size is projected to reach USD 1,512.8 million by 2026. the market was worth USD 661.6 million in 2018 and will exhibit a CAGR of 11.2% during the forecast period. Increasing Number of Product Launches Will Provide Impetus to Market Growth Pune, India, Aug. 22, 2022 (GLOBE NEWSWIRE) — The global medical carts market size is projected to reach USD 1,512.8 million by 2026. The increasing investment in technological advances will aid the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Medical Carts Market Size, Share & Industry Analysis, By Type (Anesthesia Carts, Emergency Carts, Procedure Carts, Telemedicine Carts and Others), By Material Type (Metal, Plastic, and Others), By End User (Hospitals,...

Continue reading

With 7.6% CAGR, Colorectal Cancer Therapeutics Market Size worth USD 16.58 Billion by 2026

According to Fortune Business Insights, the global Colorectal Cancer Therapeutics Market size is projected to reach USD 16.58 Billion by 2026, at CAGR of 7.6% during forecast period; Rise in Disposable Incomes and Increasing Awareness about Therapeutic Procedures to Help Asia Pacific Witness Rapid Growth Pune, India, Aug. 22, 2022 (GLOBE NEWSWIRE) — The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies,...

Continue reading

Enlivex Announces Second Quarter 2022 Financial Results and Provides a Business Update

Dosed first patient in Phase I/II trial evaluating Allocetra™ combined with chemotherapy in patients with peritoneal metastases arising from solid cancers Received Israeli Ministry of Health approval to initiate a Phase I/II trial evaluating Allocetra™ alone and in combination with a PD1 checkpoint inhibitor in patients with advanced solid tumors. Announced preclinical data in ovarian cancer (in collaboration with Yale Cancer Center) and mesothelioma showing substantial, statistically significant survival benefits when Allocetra™ is combined with PD1 or CTLA4 checkpoint inhibition, respectively Appointed new Vice Chairman of the Board, Dr. Roger J. Pomerantz, who previously served as Worldwide Head of Licensing and Acquisition and Knowledge Management at Merck & Co., Global Head of Infectious Diseases for Johnson & Johnson Pharmaceuticals,...

Continue reading

Bright Green Announces Second Quarter 2022 Financial Update and Milestone Progress

Second Quarter Results and Favorable Liquidity Position Set the Stage for Growth in Fiscal Year 2023 and Beyond GRANTS, N.M., Aug. 22, 2022 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today reported financial results for the quarter ended June 30, 2022. “This quarter has shown that Bright Green is uniquely positioned to capitalize on a growing market opportunity and deliver on our near and long-term goals as we scale our business,” said Terry Rafih, Bright Green’s Interim Chief Executive Officer and Chairman of the Board. “In May, we completed a direct...

Continue reading

Pineapple Energy Reports Second Quarter 2022 Results

Progress on key initiatives in first full quarter as publicly traded companySolid performance in core Hawaii marketProgress in building infrastructureExploring multiple routes into new market entry MINNETONKA, Minn., Aug. 22, 2022 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (“Pineapple” or the “Company”) (Nasdaq:PEGY), a leading provider of sustainable solar energy and back-up power to households and small businesses, today announced financial results for the second quarter ended June 30, 2022. “Performance in our first full quarter as a public company showed the strength of our strategy and market opportunity,” said Kyle Udseth, Pineapple CEO. “Growth was strong in our core initial market of Hawaii, especially in battery storage where installations were up 53%.” Udseth continued, “We built backlog—and thus customer relationships...

Continue reading

Tornado Global Hydrovacs Reports Second Quarter 2022 Results

Revenue Increased Significantly By 89% Compared To Q2 2021 CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) — Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TSX-V: TGH; OTCQX: TGHLF) today reported its unaudited financial and operating results for the three months period ended June 30, 2022, with comparisons to the same period last year. The unaudited condensed consolidated financial statements and related management discussion and analysis are available on the Company’s issuer profile in Canada on SEDAR at www.sedar.com, the United States at www.otcmarkets.com and on the Company’s web site www.tornadotrucks.com. All amounts reported in this news release are in thousands ($000’s CAD) except per share amounts. Second Quarter 2022 Overview and Recent DevelopmentsRevenue of $13,362 in Q2/2022 increased 89% compared...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.